ZEMBIOTECH LTD

Company Registration Number:
SC844452 (Scotland)

Unaudited statutory accounts for the year ended 30 April 2026

Period of accounts

Start date: 8 April 2025

End date: 30 April 2026

ZEMBIOTECH LTD

Contents of the Financial Statements

for the Period Ended 30 April 2026

Profit and loss
Balance sheet
Additional notes
Balance sheet notes

ZEMBIOTECH LTD

Profit And Loss Account

for the Period Ended 30 April 2026

13 months to 30 April 2026


£
Turnover: 473
Cost of sales: ( 451 )
Gross profit(or loss): 22
Administrative expenses: ( 11 )
Other operating income: 0
Operating profit(or loss): 11
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 11
Tax: 0
Profit(or loss) for the financial year: 11

ZEMBIOTECH LTD

Balance sheet

As at 30 April 2026

Notes 13 months to 30 April 2026


£
Called up share capital not paid: 0
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 402
Investments:   0
Total current assets: 402
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 3 ( 390 )
Net current assets (liabilities): 12
Total assets less current liabilities: 12
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 12
Capital and reserves
Called up share capital: 1
Share premium account: 0
Other reserves: 0
Profit and loss account: 11
Total Shareholders' funds: 12

The notes form part of these financial statements

ZEMBIOTECH LTD

Balance sheet statements

For the year ending 30 April 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 31 May 2026
and signed on behalf of the board by:

Name: Muhammad Nadeem Kardar
Status: Director

The notes form part of these financial statements

ZEMBIOTECH LTD

Notes to the Financial Statements

for the Period Ended 30 April 2026

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    All turnover arose from the company's principal activity within the United Kingdom.

    Other accounting policies

    a. Basis of Preparation The financial statements have been compiled using the historical cost convention. The company’s functional and presentational currency is Pounds Sterling (£), and all figures are presented in this currency. b. Going Concern These accounts are prepared on a going concern basis. After reviewing the company’s financial position, the director is confident that the business possesses sufficient resources to maintain operations for the foreseeable future. c. Revenue Recognition Revenue represents the fair value of money received or expected for goods sold during normal business operations. The company recognizes revenue when control of the goods transfers to the buyer, the final amount can be reliably calculated, and it is probable that the financial benefits will be received. d. Financial Instruments The company complies with Sections 11 and 12 of FRS 102 regarding financial instruments. Basic financial assets and liabilities are recorded at their transaction price at start and later tracked at amortised cost, where applicable. The company's financial instruments consist exclusively of cash at bank and the director's loan account. e. Cash and Cash Equivalents Cash and cash equivalents include all money held as cash in hand and funds stored in bank accounts. f. Taxation Current tax is calculated based on the taxable profits of the financial year. The company uses tax rates that are legally enacted or substantively enacted by the official reporting date.

ZEMBIOTECH LTD

Notes to the Financial Statements

for the Period Ended 30 April 2026

  • 2. Employees

    13 months to 30 April 2026
    Average number of employees during the period 0

ZEMBIOTECH LTD

Notes to the Financial Statements

for the Period Ended 30 April 2026

3. Creditors: amounts falling due within one year note

13 months to 30 April 2026
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Trade creditors 0
Taxation and social security 0
Accruals and deferred income 0
Other creditors 390
Total 390